Detalles de la búsqueda
1.
Decrease of the atrial fibrillatory rate, increased organization of the atrial rhythm and termination of atrial fibrillation by AZD7009.
J Electrocardiol
; 46(1): 29-35, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23219385
2.
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Europace
; 14(1): 8-27, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21791573
3.
Prediction of drug-related morphological changes of the T wave.
Scand Cardiovasc J
; 44(4): 215-22, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20429697
4.
T wave inversions following ablation of 125 posteroseptal accessory pathways.
Int J Cardiol
; 106(1): 75-81, 2006 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-16321670
5.
QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trial.
Am J Cardiovasc Drugs
; 11(3): 199-208, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21619383
6.
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Thromb Res
; 127(2): 91-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21172721
Resultados
1 -
6
de 6
1
Próxima >
>>